1989
DOI: 10.1016/0952-7915(89)90020-4
|View full text |Cite
|
Sign up to set email alerts
|

The transmission of disease to allograft recipients via donor organs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1998
1998
2015
2015

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…12,16,52,57 However, the risks of allogenic tissue include potential disease transmission, delayed incorporation, and depending on the processing technique employed, decreased graft strength and stiffness. 4,18,30,32,35,46,53,54 In several recent comparison studies, allografts have been shown as a viable alternative to autograft tissue. 14,24,[36][37][38]59 Myriad studies comparing various graft types with allografts have shown comparable results.…”
mentioning
confidence: 99%
“…12,16,52,57 However, the risks of allogenic tissue include potential disease transmission, delayed incorporation, and depending on the processing technique employed, decreased graft strength and stiffness. 4,18,30,32,35,46,53,54 In several recent comparison studies, allografts have been shown as a viable alternative to autograft tissue. 14,24,[36][37][38]59 Myriad studies comparing various graft types with allografts have shown comparable results.…”
mentioning
confidence: 99%